Title:
Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026.
The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counter drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the over-the-counter drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the over-the-counter drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the over-the-counter drugs market on global and regional basis.
Global Over-the-Counter Drugs Market: By Product
- Cough & Flu Products
- Analgesics
- Cold
- Weight Loss Products
- Mineral and Vitamin Supplements
- Gastrointestinal Products
- Ophthalmic Products
- Skin Products
- Others
Global Over-the-Counter Drugs Market: By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Contents
Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodulogy
Chapter 2. Executive Summary
- 2.1. N95 Mask Market, 2016 – 2026 (USD Million)
- 2.2. N95 Mask Market: Snapshot
Chapter 3. N95 Mask Market – Industry Analysis
- 3.1. N95 Mask Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing trend of self-medication
- 3.2.2. Growing patent expirations
- 3.3. Restraints
- 3.3.1. Concerns regarding improper diagnosis
- 3.3.2. Issues related to substance abuse
- 3.4. Opportunities
- 3.4.1. Product innovation
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Product
- 3.6.2. Market attractiveness analysis by Region
Chapter 4. N95 Mask Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global N95 Mask Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
Chapter 5. Global N95 Mask Market –Product Analysis
- 5.1. Global N95 Mask Market overview: by Product
- 5.1.1. Global N95 Mask Market share, by Product, 2019 and 2026
- 5.2. Cough & Flu Products
- 5.2.1. Global N95 Mask Market by Cough & Flu Products, 2016 – 2026 (USD Million)
- 5.3. Analgesics
- 5.3.1. Global N95 Mask Market by Analgesics, 2016 – 2026 (USD Million)
- 5.4. Culd
- 5.4.1. Global N95 Mask Market by Culd, 2016 – 2026 (USD Million)
- 5.5. Weight Loss Products
- 5.5.1. Global N95 Mask Market by Weight Loss Products, 2016 – 2026 (USD Million)
- 5.6. Mineral and Vitamin Supplements
- 5.6.1. Global N95 Mask Market by Mineral and Vitamin Supplements, 2016 – 2026 (USD Million)
- 5.7. Gastrointestinal Products
- 5.7.1. Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
- 5.8. Ophthalmic Products
- 5.8.1. Global N95 Mask Market by Ophthalmic Products, 2016 – 2026 (USD Million)
- 5.9. Skin Products
- 5.9.1. Global N95 Mask Market by Skin Products, 2016 – 2026 (USD Million)
- 5.10. Others
- 5.10.1. Global N95 Mask Market by Others, 2016 – 2026 (USD Million)
Chapter 6. Global N95 Mask Market - Regional Analysis
- 6.1. Global N95 Mask Market overview: by Region
- 6.1.1. Global N95 Mask Market share, by Region, 2019 and 2026
- 6.2. North America
- 6.2.1. North America N95 Mask Market, 2016 – 2026 (USD Million)
- 6.2.2. North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.2.3. U.S.
- 6.2.3.1. U.S. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.2.4. Rest of North America
- 6.2.4.1. Rest of North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.3. Europe
- 6.3.1. Europe N95 Mask Market, 2016 – 2026 (USD Million)
- 6.3.2. Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.3.3. UK
- 6.3.3.1. U.K. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.3.4. France
- 6.3.4.1. France N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.3.5. Germany
- 6.3.5.1. Germany N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.3.6. Rest of Europe
- 6.3.6.1. Rest of Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific N95 Mask Market, 2016 – 2026 (USD Million)
- 6.4.2. Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.4.3. China
- 6.4.3.1. China N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.4.4. Japan
- 6.4.4.1. Japan N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.4.5. India
- 6.4.5.1. India N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.4.6. Rest of Asia Pacific
- 6.4.6.1. Rest of Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America N95 Mask Market, 2016 – 2026 (USD Million)
- 6.5.2. Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.5.3. Brazil
- 6.5.3.1. Brazil N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.5.4. Rest of Latin America
- 6.5.4.1. Rest of Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
- 6.6. The Middle East and Africa
- 6.6.1. The Middle East and Africa N95 Mask Market, 2016 – 2026 (USD Million)
- 6.6.2. The Middle East and Africa N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
Chapter 7. Company Profiles
- 7.1. GlaxoSmithKline (GSK)
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Usage Portfulio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Sun Pharmaceutical Industries Ltd.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Usage Portfulio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Bayer HealthCare
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Usage Portfulio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Johnson & Johnson
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Usage Portfulio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Pfizer
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Usage Portfulio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Sanofi
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Usage Portfulio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Alkem Laboratories Limited
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Usage Portfulio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. Glenmark Pharmaceuticals Ltd.
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Usage Portfulio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Cipla, Inc.
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Usage Portfulio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. Takeda
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Usage Portfulio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Teva Pharmaceutical Industries Ltd.
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Usage Portfulio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. Reckitt Benckiser Group Plc
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Usage Portfulio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Innovus Pharmaceutical Inc.
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Usage Portfulio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. Piramal
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Usage Portfulio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Dr. Reddy's Laboratories
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Usage Portfulio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development